Development and application of adenoviral vectors for gene therapy of cancer.
about
Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growthEvaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery.Construction of avian adenovirus CELO recombinants in cosmids.Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.Anticytokine gene therapy of autoimmune diseases.Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesPharmacotherapy for biochemical recurrences after therapy for localised prostate cancer.The promise of gene therapy in gastrointestinal and liver diseases.Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.Gene therapy of liver diseases.Gene- and immunotherapy for hepatocellular carcinoma.Adenovirus as vehicle for anticancer genetic immunotherapy.HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo.Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implicationsGene therapy: regulations, ethics and its practicalities in liver disease.Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?Retargeted adenoviruses for radiation-guided gene delivery.Cancer immunotherapy: a paradigm shift for prostate cancer treatment.Vectorology and factor delivery in induced pluripotent stem cell reprogramming.Cellular unfolded protein response against viruses used in gene therapyAdenovirus-mediated expression of pig alpha(1, 3) galactosyltransferase reconstructs Gal alpha(1, 3) gal epitope on the surface of human tumor cells.Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replication.Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms.Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.Inhibition of adenovirus-mediated p27kip1 gene on growth of esophageal carcinoma cell strain.In vivo sodium iodide symporter gene therapy of prostate cancer.Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5.Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.A novel attenuated replication-competent adenovirus for melanoma therapy.Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification.Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients.Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.
P2860
Q33604559-752D1C8A-CD39-4EFA-A6BF-0581B95175E6Q33799990-41E6412F-CED2-4BB1-8493-3C60573B5B39Q33851984-6004961C-0EBF-4B92-88D5-9550A9DD8082Q34342665-FD662A88-3C36-4118-BC57-08DAFF77FFC2Q34451949-9AC8EA2D-3958-4BAA-B417-DB1D6EF1389EQ34482357-1CEA0714-E106-4E0F-991D-578E646B8403Q34660732-4AB14E4D-C57F-4860-A43A-1AAC3750A6F1Q35090229-9E9BFB36-A7BA-4C3F-9140-2FFEB7422FCBQ35192675-128C8E74-B993-482B-810C-D516C68ED872Q35842662-EF19C81E-A988-4263-9F25-F23E6A683C8DQ36150432-FA0349F4-D359-4E7E-BA9E-A9DF4B190CBAQ36288930-A578A5FA-B385-47DD-82C8-DAC42C05E8D7Q36326779-75447FA5-CB5D-46EC-8F2D-A43F8BBDC827Q36737010-B051505D-47B2-4A96-8999-2F7BFAD97DA2Q37139713-9C2776B4-5C9F-4A34-AB93-24917F284986Q37161440-F59B29EE-C09D-4BB7-B937-210E29F0E644Q37273145-DE5C830B-FD09-4925-90C6-F6C105F6559CQ38013964-5BDCBB19-EBE3-408A-829E-6FB2604E15ACQ38195650-D10558DC-FB3A-4108-8FBE-0B31852807E3Q38218111-BE764EDC-B111-4DA7-B60E-BC656E3F982EQ38299022-6B730BD7-3ACB-4833-B16E-3249412804E1Q39894493-FF528168-1097-4F0E-BAAB-054045E0F098Q40189728-D11642F2-36D4-47CC-A0BA-D5B80214BE4DQ40369834-FAC22187-5669-4693-BDBA-0EA2742E7D2EQ40418669-4E81B885-C6F9-4590-B009-98C72ED46AEAQ40551014-E8B9D188-9E2A-448C-A8C2-45C8BC293CEDQ40618647-FE0927C6-2A07-4B16-BACA-1AA00F0B108DQ40769277-609018A1-BC14-4EC7-97EF-FFFCA3BC8FECQ41453719-8E2FB66B-2465-4851-B2D7-FACAD931BBC1Q43501855-5943176C-37A7-4ED0-BD24-8BC048B16310Q44303896-5084C72B-FC11-4000-9739-1D4097AABF3CQ44620329-9E82BB70-15A8-4797-B5D4-D69E33297405Q45863293-D4251DF0-E216-48D2-B667-DD459A482667Q45867352-60778632-B5A6-45DE-8F24-452B72366B70Q45875626-41904DF1-3A7B-4924-927D-7EC45A71C2EF
P2860
Development and application of adenoviral vectors for gene therapy of cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development and application of adenoviral vectors for gene therapy of cancer.
@ast
Development and application of adenoviral vectors for gene therapy of cancer.
@en
Development and application of adenoviral vectors for gene therapy of cancer.
@nl
type
label
Development and application of adenoviral vectors for gene therapy of cancer.
@ast
Development and application of adenoviral vectors for gene therapy of cancer.
@en
Development and application of adenoviral vectors for gene therapy of cancer.
@nl
prefLabel
Development and application of adenoviral vectors for gene therapy of cancer.
@ast
Development and application of adenoviral vectors for gene therapy of cancer.
@en
Development and application of adenoviral vectors for gene therapy of cancer.
@nl
P356
P1433
P1476
Development and application of adenoviral vectors for gene therapy of cancer.
@en
P2093
P2888
P304
P356
10.1038/SJ.CGT.7700024
P577
1999-03-01T00:00:00Z
P5875
P6179
1001612924